Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical Trials

OBJECTIVE. To characterize hydroxychloroquine exposure in patients with rheumatic disease receiving long-term hydroxychloroquine compared to target concentrations with reported antiviral activity against the 2019 coronavirus SARS-CoV-2. METHOD. We evaluated total hydroxychloroquine concentrations in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Rheumatol
Main Authors: Balevic, Stephen J., Hornik, Christoph P., Green, Thomas P., Clowse, Megan E.B., Gonzalez, Daniel, Maharaj, Anil R., Schanberg, Laura E., Eudy, Amanda M., Swamy, Geeta K., Hughes, Brenna L., Cohen-Wolkowiez, Michael
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7655510/
https://ncbi.nlm.nih.gov/pubmed/32393664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.200493
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados